Advertisement

European Journal of Clinical Pharmacology

, Volume 31, Issue 5, pp 541–545 | Cite as

Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis

  • B. A. C. Dijkmans
  • A. W. A. M. van Rijthoven
  • H. S. Goei The
  • Z. L. B. M. Montnor-Beckers
  • P. C. J. Jacobs
  • A. Cats
Originals

Summary

Serum creatinine levels were measured before, during and after the administration of cyclosporin (Cy) in a double-blind placebo-controlled study in patients with rheumatoid arthritis (RA). The level rose significantly during and after Cy therapy, whereas the initial serum creatinine value did not change in the placebo group. The increase in the Cy group was not correlated with the mean Cy blood level. The rise in serum creatinine during Cy therapy was gradual and was not significantly correlated with the initial creatinine level; relative to the pretreatment value, the post-treatment increase was significantly correlated with the increase during Cy therapy. It is concluded that Cy administration for not more than 6 months, and at a maximum dosage of 10 mg/kg for 2 months, leads to an irreversible loss of more than 10% of renal function in RA patients. The damage may be ascribed to the combination of Cy with other factors compromising the kidneys, e.g., the use of non-steroidal anti-inflammatory drugs in the potentially systemic disorder of RA.

Key words

cyclosporin rheumatoid arthritis serum creatinine renal damage serum cyclosporin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Calne RY, White DJG, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Pentlow BD, Rolles K (1978) Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 2: 1323–1327Google Scholar
  2. 2.
    Myers BD, Ross J, Newton L, Luetscher J, Perlroth M (1984) Cyclosporin-associated chronic nephropathy. N Engl J Med 311: 699–705Google Scholar
  3. 3.
    Chapman JR, Griffiths D, Harding NGL, Morris PJ (1985) Reversibility of cyclosporin nephrotoxicity after three months' treatment. Lancet 1: 128–129Google Scholar
  4. 4.
    Henny FC, Kleinbloesem CH, Moolenaar AJ, Paul LC, Breimer DD, Van Es LA (1985) Pharmacokinetics and nephrotoxicity of cyclosporin A in renal transplant recipients. Transplantation 40: 261–265Google Scholar
  5. 5.
    Palestine AG, Nussenblatt RB, Chi-Chao Chan (1984) Side-effects of systemic cyclosporin in patients not undergoing transplantation. Am J Med 77: 652–656Google Scholar
  6. 6.
    Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31–41Google Scholar
  7. 7.
    Donatsch P, Abisch E, Homberger M, Traber R, Trapp M, Voges R (1981) A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J Immunoassay 2: 19–32.Google Scholar
  8. 8.
    Van Rijthoven AWAM, Dijkmans BAC, Goei The HS, Hermans J, Montnor-Beckers ZLBM, Jacobs PJC, Cats A (1986) Cyclosporin treatment for rheumatoid arthritis: A placebo-controlled double-blind multicentre study. Ann Rheum Dis 45: 726–731Google Scholar
  9. 9.
    Strom TB, Loertscher R (1984) Cyclosporin-induced nephrotoxicity. N Engl J Med 311: 728–729Google Scholar
  10. 10.
    Dijkmans BAC, van Hooff JP, de Wolff FA, Mattie M (1981) The effect of co-trimoxazole on serum creatinine. Br J Clin Pharmacol 12: 701–703Google Scholar
  11. 11.
    Morris PJ, French ME, Dunnhill MS, Hunnisett AGW, Ting A, Thompson JF, Wood RFM (1983) A controlled trial of cyclosporin in renal transplantation with conversion to azathioprine and prednisolone after three months. Transplantation 36: 273–277Google Scholar
  12. 12.
    Nived O, Sturfelt G, Westling H, White T (1983) Is serum creatinine concentration a reliable index of renal function in rheumatic diseases? Br Med J 286: 684–685Google Scholar
  13. 13.
    Breedveld FC, Valentijn RM, Westedt ML, Weening J (1985) Rapidly progressive glomerulonephritis with glomerular crescent formation in rheumatoid arthritis. Clin Rheumatol 4: 353–359Google Scholar
  14. 14.
    Kimberly RP, Bowden RE, Keiser HR, Plotz PH (1978) Reduction of renal function by newer nonsteroidal anti-inflammatory drugs. Am J Med 64: 804–807Google Scholar
  15. 15.
    Wegmueller E (1985) Nicht-steroidale Antirheumatika und Nephrotoxizität. Dtsch Med Wochenschr 110: 469–472Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • B. A. C. Dijkmans
    • 1
  • A. W. A. M. van Rijthoven
    • 2
  • H. S. Goei The
    • 3
  • Z. L. B. M. Montnor-Beckers
    • 2
  • P. C. J. Jacobs
    • 3
  • A. Cats
    • 1
  1. 1.Department of RheumatologyUniversity HospitalLeidenThe Netherlands
  2. 2.Deaconess HospitalEindhovenThe Netherlands
  3. 3.De Wever HospitalHeerlenThe Netherlands

Personalised recommendations